Breaking News, Collaborations & Alliances

NovaMedica, Aptalis Sign Russian Distribution Pact

To develop and commercialize three gastrointestinal products

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

NovaMedica has signed a partnership agreement with Aptalis Pharma to develop and commercialize three of Aptalis’ gastrointestinal products in Russia. The products include Pylera, indicated for the eradication of Helicobacter Pylori in patients with gastric or duodenal ulcer; Lacteol, a product derived from a human strain of Lactobacillus LB for use in patients with diarrhea; and Panzytrat, a formulation of pancreatic enzymes indicated for maldigestion due to exocrine pancreatic insufficien...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters